Oracle Corp

Oracle Corp(ORCL)股票分析

$125.540

-3.490 (-2.78%)收盘时

Loading chart…
最高
127.940
开盘
126.350
成交量加权均价
125.41
成交量
36.58M
市值
386.32B
最低
122.760
成交额
4.59B
企业价值/息税折旧摊销前利润(TTM)
8.95

Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies.

AI 分析 of Oracle Corp (ORCL)

卖出

Oracle Corp is not a good buy right now due to its current price of $128.23, which is significantly down 34.48% year-to-date and 53.74% over the past year. The RSI is at 34.316, indicating oversold conditions, but the negative trend in gross margin, which has decreased to 62.97%, raises concerns about profitability. Additionally, the company faces a high debt burden, with a CDS spread approaching 300 basis points, indicating market skepticism about its financial stability.

分析师评级(36)

上行空间 +146.61%
买入
26 买入
9 持有
1 卖出
当前: 125.54
最低
180.00
平均
309.59
最高
400.00

Freedom Broker

2026-09-14

目标价

$205

买入

BMO Capital

2026-09-11

目标价

$195

跑赢大盘

UBS

2026-09-11

目标价

$250

买入

RBC Capital

2026-09-11

目标价

$165

Sector Perform

Stifel

2026-09-11

目标价

$200

买入

估值指标

Oracle Corp(ORCL)当前预期市盈率为 17.76,5 年平均预期市盈率为 22.46。

预期市盈率

合理
5 年均值 P/E
22.46
当前P/E
17.76
高估
30.89
低估
14.04

预期 EV/EBITDA

低估
5 年均值 EV/EBITDA
14.80
当前EV/EBITDA
8.95
高估
18.22
低估
11.38

预期市销率

低估
5 年均值 P/S
5.91
当前P/S
3.02
高估
7.88
低估
3.93

Alphio AI 对 ORCL 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ORCL

$183.84

情景价格

基

基准

基准 · 50%ORCL

$164.06

情景价格

悲

悲观

悲观 · 25%ORCL

$142.46

情景价格

持有 ORCL 的大户

C

Corient Private Wealth LP

+ 持有ORCL

+49.48%

3个月收益率

L

Loomis, Sayles & Company L.P.

+ 持有ORCL

+9.54%

3个月收益率

B

Brighton Jones LLC

+ 持有ORCL

+9.19%

3个月收益率

L

LGT Fund Management Company AG

+ 持有ORCL

+9.14%

3个月收益率

D

Diversify Wealth Management, LLC

+ 持有ORCL

+8.88%

3个月收益率

C

Compound Global Advisors, LLC

+ 持有ORCL

+8.85%

3个月收益率

ORCL 常见问题 —— 由 Alphio AI 解答

Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).

Oracle Corp is not a good buy right now due to its current price of $128.23, which is significantly down 34.48% year-to-date and 53.74% over the past year. The RSI is at 34.316, indicating oversold conditions, but the negative trend in gross margin, which has decreased to 62.97%, raises concerns about profitability. Additionally, the company faces a high debt burden, with a CDS spread approaching 300 basis points, indicating market skepticism about its financial stability.

36 analysts cover ORCL: 26 rate it Buy, 9 Hold and 1 Sell. The average price target is 309.59.

AstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes Partnership aims to advance solutions to improve care pathways, clinical trial matching, safety monitoring, and guideline-directed care AstraZeneca and Oracle Health and Life Sciences today announced a unique collaboration to leverage AstraZeneca's scientific, clinical development and regulatory expertise with Oracle's real-world data, cloud infrastructure, and AI-enabled clinical capabilities to accelerate clinical research and bring evidence-driven insights into care workflows to accelerate clinical trial optimisation and help more patients receive the right care sooner. $AZN $ORCL

展开

$ORCL is starting to look very enticing on the weekly chart! The $110-125 support area would be an excellent spot to build a long term position (or common shares) as this area has been respected four times in the last two years! The GEX Heatmap shows the stock surrounded by negative Gamma with the King Node at $145 for October 30th! 👀

展开
注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易